Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a scan before birth predict a Baby's heart defect?

NCT ID NCT07820163

Diagnosis Sponsor: Assiut University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 15, 2026 · Last updated Sep 17, 2026 · Updated 2 times

Summary

Researchers at Assiut University Hospitals are studying how well fetal heart scans before birth match the heart diagnoses babies receive after delivery. The study includes pregnant women referred for fetal echocardiography and newborns with confirmed critical congenital heart disease. By comparing prenatal and postnatal diagnoses, the team aims to understand whether early detection affects newborn survival and the need for emergency heart procedures.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If prenatal heart scans match newborn diagnoses well, hospitals could rely on them more to plan deliveries and newborn care. Better planning may help babies with heart defects get treatment sooner.
What could go wrong
This is an observational study, so it cannot prove that prenatal diagnosis causes better outcomes. Scans can miss or misread heart defects, and results from one hospital may not apply elsewhere.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 115 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

May 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Pregnant women referred for fetal echocardiography due to suspected or confirmed congenital heart disease, and neonates with prenatally or postnatally confirmed CHD at Assiut University Hospitals.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria (Postnatal arm):: * \- Term neonates with confirmed critical CHD * Neonates with prenatal CHD diagnosis or postnatal first-time diagnosis * Parental written informed consent Inclusion Criteria (Prenatal arm): * Singleton pregnancies referred for fetal echocardiography between 18 and 36+6 weeks * Suspected cardiac abnormalities on routine obstetric scan * Written informed consent Exclusion Criteria: * \- Multiple gestations * Fetuses with growth restriction (EFW or AC below 3rd percentile) * Premature infants (\<37 weeks) * Neonates with stable CHD not requiring intervention * Incomplete records or loss to follow-up

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Congenital heart disease are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

congenital heart disease Fetal Diseases Infant, Newborn, Diseases

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Congenital heart disease Fetal disease Fetal heart disorder Neonatal disease

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.